BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1148 related articles for article (PubMed ID: 8757136)

  • 1. Functional interaction of beta-catenin with the transcription factor LEF-1.
    Behrens J; von Kries JP; Kühl M; Bruhn L; Wedlich D; Grosschedl R; Birchmeier W
    Nature; 1996 Aug; 382(6592):638-42. PubMed ID: 8757136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1.
    Huber O; Korn R; McLaughlin J; Ohsugi M; Herrmann BG; Kemler R
    Mech Dev; 1996 Sep; 59(1):3-10. PubMed ID: 8892228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
    Simcha I; Shtutman M; Salomon D; Zhurinsky J; Sadot E; Geiger B; Ben-Ze'ev A
    J Cell Biol; 1998 Jun; 141(6):1433-48. PubMed ID: 9628899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex.
    Mei JM; Borchert GL; Donald SP; Phang JM
    Carcinogenesis; 2002 Dec; 23(12):2119-22. PubMed ID: 12507936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
    Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
    J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes.
    Gottardi CJ; Gumbiner BM
    J Cell Biol; 2004 Oct; 167(2):339-49. PubMed ID: 15492040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression.
    Prieve MG; Waterman ML
    Mol Cell Biol; 1999 Jun; 19(6):4503-15. PubMed ID: 10330189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.
    Novak A; Hsu SC; Leung-Hagesteijn C; Radeva G; Papkoff J; Montesano R; Roskelley C; Grosschedl R; Dedhar S
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4374-9. PubMed ID: 9539744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
    Henderson BR; Galea M; Schuechner S; Leung L
    J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF.
    Ishitani T; Ninomiya-Tsuji J; Nagai S; Nishita M; Meneghini M; Barker N; Waterman M; Bowerman B; Clevers H; Shibuya H; Matsumoto K
    Nature; 1999 Jun; 399(6738):798-802. PubMed ID: 10391247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators.
    Kim K; Pang KM; Evans M; Hay ED
    Mol Biol Cell; 2000 Oct; 11(10):3509-23. PubMed ID: 11029052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin.
    Hsu SC; Galceran J; Grosschedl R
    Mol Cell Biol; 1998 Aug; 18(8):4807-18. PubMed ID: 9671490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCF/LEF factor earn their wings.
    Clevers H; van de Wetering M
    Trends Genet; 1997 Dec; 13(12):485-9. PubMed ID: 9433138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of beta-catenin-mediated transactivation by cadherin derivatives.
    Sadot E; Simcha I; Shtutman M; Ben-Ze'ev A; Geiger B
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15339-44. PubMed ID: 9860970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway.
    Takemaru K; Yamaguchi S; Lee YS; Zhang Y; Carthew RW; Moon RT
    Nature; 2003 Apr; 422(6934):905-9. PubMed ID: 12712206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors.
    Levanon D; Goldstein RE; Bernstein Y; Tang H; Goldenberg D; Stifani S; Paroush Z; Groner Y
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11590-5. PubMed ID: 9751710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel isoform of human lymphoid enhancer-binding factor-1 (LEF-1) gene transcript encodes a protein devoid of HMG domain and nuclear localization signal.
    Kobielak A; Kobielak K; Trzeciak WH
    Acta Biochim Pol; 2001; 48(1):221-6. PubMed ID: 11440173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.